Item 1.01. Entry into a Material Definitive Agreement.

On December 30, 2022, BIOLASE, Inc., a Delaware corporation (the "Company"), entered into the Tenth Amendment to Credit Agreement (the "Tenth Amendment") with SWK Funding LLC ("SWK"), in connection with that certain Credit Agreement (the "Credit Agreement"), by and among the Company, SWK, and the lender parties thereto. The Tenth Amendment amends the Credit Agreement by reducing the required minimum consolidated unencumbered liquid assets from $3,000,000 to $2,500,000 and removing the conditional minimum last twelve months aggregate revenue and Earnings Before Interest, Taxes, Depreciation and Amortization ("EBITDA") as of the end of the twelve month period ending December 31, 2022. The Tenth Amendment contains representations, warranties, covenants, releases, and conditions customary for a credit agreement amendment of this type.

The foregoing summary of the Tenth Amendment does not purport to be complete and is qualified in their entirety by reference to the Tenth Amendment, a copy of which is attached hereto as Exhibit 10.1, which is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.




(d) Exhibits.

Exhibit
  No.                                    Description

10.1          Tenth Amendment to Credit Agreement, dated as of December 30, 2022,
            by and among BIOLASE, INC., each of the Lenders, and SWK FUNDING LLC,
            in its capacity as administrative agent for the other Lenders

104         Cover Page Interactive Data File (embedded within the Inline XBRL
            document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses